CureVac NV Earnings Estimate

CVAC Stock  USD 3.79  0.03  0.79%   
By analyzing CureVac NV's earnings estimates, investors can diagnose different trends across CureVac NV's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for CureVac NV is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
CureVac NV is projected to generate -0.805 in earnings per share on the 31st of December 2021. CureVac NV earnings estimates show analyst consensus about projected CureVac NV EPS (Earning Per Share). It derives the highest and the lowest estimates based on CureVac NV's historical volatility. Many public companies, such as CureVac NV, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing CureVac NV's earnings estimates, investors can diagnose different trends across CureVac NV's analyst sentiment over time as well as compare current estimates against different timeframes. As of February 2, 2025, Gross Profit is expected to decline to about (66.7 M). In addition to that, Pretax Profit Margin is expected to decline to -4.57
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CureVac NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade CureVac Stock refer to our How to Trade CureVac Stock guide.

CureVac NV Earnings per Share Projection vs Actual

About CureVac NV Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of CureVac NV earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current CureVac NV estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as CureVac NV fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-1.4 B-1.5 B
Earnings Yield(0.36)(0.34)
Price Earnings Ratio(2.91)(3.05)
Price Earnings To Growth Ratio 0.27  0.29 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether CureVac NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CureVac NV's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Curevac Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Curevac Nv Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CureVac NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade CureVac Stock refer to our How to Trade CureVac Stock guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CureVac NV. If investors know CureVac will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CureVac NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.49
Revenue Per Share
0.294
Quarterly Revenue Growth
0.905
Return On Assets
(0.25)
Return On Equity
(0.54)
The market value of CureVac NV is measured differently than its book value, which is the value of CureVac that is recorded on the company's balance sheet. Investors also form their own opinion of CureVac NV's value that differs from its market value or its book value, called intrinsic value, which is CureVac NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CureVac NV's market value can be influenced by many factors that don't directly affect CureVac NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CureVac NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if CureVac NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CureVac NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.